ScholarLens Back to search
1990•Kitakantou igaku/Kitakantō IgakuOpen access

PARTIAL LIPIODOL/TRANSCATHETER ARTERIAL EMBOLIZATION FOR TREATMENT OF MALIGNANT HEPATIC TUMORS

TOSHIHIDE IIJIMA, Masao Ohsumi, Hiroshi Koitabashi, Masayuki Shiojima, Takahiro Kojima, Kimitaka Kogure, Masatoshi Ishizaki, Norio Akiyama, HARUTOSHI OHNO

Open full text 0 citations

Abstract

Ten cases of malignant hepatic tumor (3 hepatic metastases and 7 primary hepato-cellular carcinomas) were treated by partial Lipiodol/transcatheter arterial embolization, in which lipiodol and anticancer drug mixed with gelfoam powder were administered alternately. The hepatic blood flow was not blocked completely by embolization. All cases were followed for more than one year.1) The changes in hepatic function were similar to those with conventional TAE.2) The one-year survival rate was 70.0%, and two-year survival rate was 52.9%.

Open-access reader

About this research paper

What this paper is about

Ten cases of malignant hepatic tumor (3 hepatic metastases and 7 primary hepato-cellular carcinomas) were treated by partial Lipiodol/transcatheter arterial embolization, in which lipiodol and anticancer drug mixed with gelfoam powder were administered alternately. The hepatic blood flow was not blocked completely by embolization. All cases were followed for more than one year.1) The changes in hepatic function were similar to those with conventional TAE.2) The one-year survival rate was 70.0%, and two-year survival rate was 52.9%.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ten cases of malignant hepatic tumor (3 hepatic metastases and 7 primary hepato-cellular carcinomas) were treated by partial Lipiodol/transcatheter arterial embolization, in which lipiodol and anticancer drug mixed with gelfoam powder were administered alternately. The hepatic blood flow was not blocked completely by embolization. All cases were followed for more than one year.1) The changes in hepatic function were similar to those with conventional TAE.2) The one-year survival rate was 70.0%, and two-year survival rate was 52.9%.

Key concepts: Lipiodol, Arterial Embolization, Medicine, Embolization, Survival rate, Blood flow, Hepatic function, Radiology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
PARTIAL LIPIODOL/TRANSCATHETER ARTERIAL EMBOLIZATION FOR TREATMENT OF MALIGNANT HEPATIC TUMORS — Research Paper | ScholarLens